Sanofi announces management reshuffle

16 February 2009

France's Sanofi Aventis has continued its restructuring under its new chief executive with a management reshuffle. The firm has created the  new position of chief strategic officer and promoted chief financial  officer Laurence Debroux into the role. Meanwhile, Sanofi has appointed  Jean-Pierre Lehner as chief medical officer. Dr Lehner was previously  senior vice president of medial and regulatory affairs. The company also  hired former US National Institutes of Health chief Elias Zerhouni as  scientific advisor to the new CEO.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight